DaVita(US:DVA) ZACKSยท2024-06-26 23:20Company Overview - DaVita HealthCare (DVA) ended the latest trading session at $142.16, reflecting a -0.53% adjustment from the previous day's close, underperforming the S&P 500's 0.16% gain [3] - Over the last month, DaVita's shares decreased by 0.52%, while the Medical sector gained 2.32% and the S&P 500 increased by 3.22% [3] Earnings Performance - DaVita is expected to report an EPS of $2.47, indicating an 18.75% growth compared to the same quarter last year [4] - The consensus estimate for revenue is $3.16 billion, showing a 5.43% increase compared to the year-ago quarter [4] - For the entire year, the Zacks Consensus Estimates forecast earnings of $9.62 per share and revenue of $12.74 billion, reflecting changes of +13.58% and +4.97% respectively compared to the previous year [5] Analyst Estimates and Rankings - Recent changes to analyst estimates for DaVita HealthCare suggest positive business outlooks, as these revisions often reflect short-term business dynamics [5] - DaVita currently holds a Zacks Rank of 2 (Buy), with no change in the Zacks Consensus EPS estimate over the past month [6] Valuation Metrics - DaVita HealthCare is trading at a Forward P/E ratio of 14.85, which is a discount compared to the industry average Forward P/E of 23.18 [7] - The company has a PEG ratio of 1.09, compared to the industry average PEG ratio of 1.96 [7] Industry Context - The Medical - Outpatient and Home Healthcare industry, which includes DaVita, has a Zacks Industry Rank of 27, placing it in the top 11% of over 250 industries [8] - The Zacks Industry Rank measures the strength of industry groups based on the average Zacks Rank of individual stocks, indicating that top-rated industries outperform the bottom half by a factor of 2 to 1 [8]